Ricardo Harvin<p>Great news! I guess this is the next best thing to an unpatented vaccine for HIV protection.</p><p>Twice yearly injection with royalty-free licensing waived for the production of low cost generics for two million people in the poorest areas with the greatest need.</p><p><a href="https://mstdn.social/tags/libk" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>libk</span></a>: <a href="https://newatlas.com/infectious-diseases/hiv-prevention-fda-lenacapavir/" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">newatlas.com/infectious-diseas</span><span class="invisible">es/hiv-prevention-fda-lenacapavir/</span></a></p><p><a href="https://mstdn.social/tags/HIV" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>HIV</span></a> <a href="https://mstdn.social/tags/lenacapavir" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>lenacapavir</span></a> <a href="https://mstdn.social/tags/Yeztugo" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Yeztugo</span></a> <a href="https://mstdn.social/tags/CapsidInhibitor" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>CapsidInhibitor</span></a> <a href="https://mstdn.social/tags/PrEP" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>PrEP</span></a> <a href="https://mstdn.social/tags/AIDS" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>AIDS</span></a></p>